Document is current
Any future updates will be listed below
-
Authors
Hammer, Alexander
Goettling, Marc
Malberg, Hagen
Linke, Axel
Richter, Sergio
Mangner, Norman
Schmidt, Martin
-
Funding
Funding for this research was provided by:
Horizon 2020 (101017424)
- License Information
-
More Information
Article History
Received: 28 June 2024
Accepted: 3 July 2025
First Online: 28 August 2025
Competing interests
: A.H., M.G., H.M., and M.S. are the inventors of the patent application DE 10 2023 118 246.3, which covers the principle of xFuseMap presented in this paper and the architecture of xECGArch. The TU Dresden is the patent applicant. A.L. and S.R. have received grants from Novartis and Edwards Lifesciences; personal fees from Abbott, Abiomed, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Edwards Lifesciences, Medtronic, Novartis, Sanofi Genzyme, and Pfizer; and other fees from Picardia, Filterlex, and Transverse Medical outside the submitted work. N.M. reports personal fees from Edwards Lifesciences, Medtronic, Biotronik, Novartis, Sanofi Genzyme, AstraZeneca, Pfizer, Bayer, Abbott, Abiomed, B. Braun, and Boston Scientific, outside the submitted work.
